1. Home
  2. PHGE vs GWAV Comparison

PHGE vs GWAV Comparison

Compare PHGE & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • GWAV
  • Stock Information
  • Founded
  • PHGE 2015
  • GWAV 2002
  • Country
  • PHGE Israel
  • GWAV United States
  • Employees
  • PHGE N/A
  • GWAV N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • GWAV Packaged Foods
  • Sector
  • PHGE Health Care
  • GWAV Consumer Staples
  • Exchange
  • PHGE Nasdaq
  • GWAV Nasdaq
  • Market Cap
  • PHGE 26.5M
  • GWAV 8.2M
  • IPO Year
  • PHGE N/A
  • GWAV N/A
  • Fundamental
  • Price
  • PHGE $0.95
  • GWAV $0.56
  • Analyst Decision
  • PHGE Strong Buy
  • GWAV
  • Analyst Count
  • PHGE 2
  • GWAV 0
  • Target Price
  • PHGE $22.50
  • GWAV N/A
  • AVG Volume (30 Days)
  • PHGE 35.5K
  • GWAV 1.3M
  • Earning Date
  • PHGE 11-12-2024
  • GWAV 11-12-2024
  • Dividend Yield
  • PHGE N/A
  • GWAV N/A
  • EPS Growth
  • PHGE N/A
  • GWAV N/A
  • EPS
  • PHGE N/A
  • GWAV N/A
  • Revenue
  • PHGE N/A
  • GWAV $33,594,958.00
  • Revenue This Year
  • PHGE N/A
  • GWAV N/A
  • Revenue Next Year
  • PHGE N/A
  • GWAV N/A
  • P/E Ratio
  • PHGE N/A
  • GWAV N/A
  • Revenue Growth
  • PHGE N/A
  • GWAV 5.60
  • 52 Week Low
  • PHGE $0.88
  • GWAV $0.37
  • 52 Week High
  • PHGE $8.55
  • GWAV $154.50
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 38.91
  • GWAV 65.18
  • Support Level
  • PHGE $0.92
  • GWAV $0.37
  • Resistance Level
  • PHGE $0.99
  • GWAV $0.44
  • Average True Range (ATR)
  • PHGE 0.06
  • GWAV 0.04
  • MACD
  • PHGE 0.02
  • GWAV 0.02
  • Stochastic Oscillator
  • PHGE 32.64
  • GWAV 69.46

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company's products are selling ferrous metal, which is used in the recycling and production of finished steel. It is categorized into heavy melting steel, plate and structural, and shredded scrap. and it also processes nonferrous metals such as aluminum, copper, stainless steel, nickel, brass, titanium, alloys, and mixed metal products.

Share on Social Networks: